G3m(st+)(u-)(b+)(g-), G3m(st-)(u+)(b+)(g-), G3m(st-)(u+)(b-)(g+), and G3m(st-) (u-)(b-)(g+) phenotypes. The binding of human IgG3 to M12 protein seems to be related to features other than its Gm allotypic markers. Selective reactivity of IgG3 myeloma proteins with M12 protein may provide another way to subclassify human IgG3 molecules. The biological significance of the selective reactivity is not known.
Group A streptococci are capable of highly specific interaction with a number of human proteins, including immunoglobulins (Ig), fibrinogen, and albumin, by means of structures on the bacterial surface (12) (13) (14) . Bacterial surface protein has the ability to bind IgG by the Fc part of the Ig (5, 13) . The IgG Fc-binding proteins have been designated type II receptors (2) . A further subdivision of type II receptors has been made according to their abilities to react with various human IgG subclasses. Thus, type Ila receptors bind human IgGl, IgG2 , and IgG4 and rabbit and pig Ig, while type IIb receptors interact only with human IgG3 (30) .
The M proteins are fibrillar molecules on the streptococcal surface. These complex antigens determine the type specificity of group A streptococci and are important factors in virulence (6, 8) . Some streptococcal M proteins possess the ability to bind fibrinogen (21, 26) and albumin (21) . It has been suggested that streptococcal Fc-binding proteins and M proteins actually constitute two distinct proteins (9, 10, 16) . However, affinity-purified M protein and strains which express an Mrelated protein which binds both fibrinogen and Ig have now been described (21, 24) .
The M12 protein from Streptococcus pyogenes CS24 has recently been shown to be a human IgG3-binding protein (19) . The gene coding for M12 protein, emml2, has been cloned, and the binding site for IgG has been located in a peptide encoded by a PvuII fragment internal to the gene (19) . We have investigated the ability of this truncated recombinant M12 protein to bind various monoclonal human IgG3 myeloma proteins representing a number of both Caucasian and Oriental IgG3 Gm(allotypic) phenotypes.
The fact that some streptococcal M proteins, such as M12, have the ability to bind human albumin as well as Ig (19, 21) was utilized when recombinant M12(pPvu) protein was purified from crude bacterial extracts. The construction from group A streptococcal strain CS24 of a recombinant Escherichia coli strain, E. coli(pPvu), which produces a truncated recombinant M12 protein that binds human IgG3 has been described previously (18) (19) (20) 22) . Crude extracts of E. coli (pPvu) containing the peptide encoded by the PvuII fragment were dialyzed against 0.05 M Tris buffer, pH 7.5. In order to purify the recombinant M12(pPvu) protein, the extracts were added to a Sepharose 4B column (Pharmacia Fine Chemicals, Piscataway, N.J.) linked with human albumin (Sigma fraction V; Sigma Chemical Company, St. Louis, Mo.) (7) . Nonbound material was washed off the column with 0.05 M Tris (pH 7.4)-0.1 M NaCl buffer. Bound protein was eluted with 2 M potassium thiocyanide (Sigma) and analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (15) on a gradient gel (5 to 20%) under nonreducing conditions. After staining with Coomassie brilliant blue, the eluted protein showed a main band with a molecular mass of around 47 kDa (data not shown), which was roughly in accordance with the 43 kDa known for recombinant M12(pPvu) protein (19) . Further verification that the protein isolated was the recombinant M12(pPvu) protein was its ability to react with M12-specific rabbit antiserum when tested by enzyme-linked immunosorbent assay (ELISA) (see below). The eluted protein was dialyzed against phosphate-buffered saline (PBS) before being used in the binding assays.
Rabbit antiserum to the M12 protein from S. pyogenes CS24 was produced as previously described (23 Oriental patients. All IgG3 myeloma proteins were studied for expression of Gm(bO), Gm(bl), and Gm(b3) (Caucasoid Gm allotypic markers associated with IgG3) as well as Gm(s), Gm(t), and Gm(u) (Oriental Gm IgG3 allotypic markers). In parallel, Gm(g) typing was also performed on all IgG3 myelomas studied. Gm markers on individual myeloma proteins were identified by inhibition of agglutination of known anti-Gm agglutinators and human Rh-positive erythrocytes coated with incomplete human IgG antibodies bearing well-defined Gm(b), Gm(s)(t) or (u), and Gm(g) markers (27, 28 (Fig. la) . These findings ruled out the possibility that the previous results were due to competition at the binding site on the IgG molecule between recombinant M12(pPvu) protein and protein G. The binding sites for recombinant M12(pPvu) protein and protein G on the IgG molecule are therefore not likely to be identical.
The presence of adequate amounts of recombinant M12(pPvu) protein on the ELISA plate was ensured by the binding of rabbit anti-M12 antibodies (Fig. la) . Rabbit anti-M12 antibody at a dilution of 1:5,000 in PBS-BSA-Tween was added to recombinant M12(pPvu) protein-coated wells and incubated for 2 h. The binding of the rabbit antibody was detected with peroxidase-conjugated goat F(ab')2 anti-rabbit IgG (Jackson Immuno Laboratories) diluted 1:7,500 in PBS-BSA-Tween.
In binding experiments with wells coated with either human IgG Fc fragment, F(ab')2 fragment, or human IgG myeloma proteins, 20 ,ug of recombinant M12(pPvu) protein per ml in PBS-BSA-Tween was allowed to bind for 2 h. After the wells were washed, rabbit anti-M12 antibodies diluted 1:5,000 in PBS-BSA-Tween were added, and incubation was continued for another 2 h. After the wells were washed, peroxidaseconjugated goat F(ab')2 anti-rabbit IgG, diluted 1:7,500 in 
